Alisertib
CAS: 1028486-01-2
Molecular Formula: C27H20ClFN4O4
Molecular weight:518.9235032
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :Alisertib is an orally available selective aurora A kinase inhibitor developed by Takeda. It was investigated as a treatment for relapsed or refractory peripheral T-cell lymphoma.
Disclaimer: the information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.
for: Product Quotation ( Product suppliers),COA (Certificate of Analysis), New Sales
Promotion,New Products,And any other assistance.
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@aushealthingredients.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6516 2351
4. Send enquiry online: